Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

What "newest" means here

The most recent study in this library is dated 2026-11-01 (Paths of Aging Minds: Health Journeys of Older Adults with Mild Cognitive Impairment). This is our summary library, not a news wire — it is added to in batches, so the newest entry may not be the newest paper published anywhere.

Entries are sorted strictly by publication date, newest first. 26489 of the 27380 entries carry a full day-level date. 65 have no date recorded at all and are placed by publication year, at the start of that year; those are marked "no date recorded" below so you can see where the ordering is a best effort rather than a fact.

Prefer a reader? Subscribe to the Atom feed. Want them sorted by subject or by score instead? Browse the research library.

Showing 1,626–1,650 of 27,380 studies, newest first · page 66 of 1096.

March 2026 16

  1. 2026-03 month only

    Effectiveness, safety, and biomarker dynamics of lecanemab in Chinese Alzheimer's disease population: a multicenter real-world study

    ✓ Peer-reviewed Biomarkers Alzheimer's & dementia : the journal of the Alzheimer's Association

    Key finding: Lecanemab significantly attenuated cognitive decline versus ADNI. +4 more findings

  2. 2026-03-01

    Advance care planning in Medicare beneficiaries with Alzheimer's disease and related dementias

    ✓ Peer-reviewed End-of-life care Alzheimer s & Dementia Behavior & Socioeconomics of Aging

    Key finding: ACP is linked to lower EOL spending and a shift from inpatient to outpatient ADRD care; structured ACP delivery should be considered.

  3. 2026-03-01

    Co‐Design of a Sleep Improvement Intervention for Persons Living With Dementia Boarding in the Emergency Department

    ✓ Peer-reviewed Clinical safety Academic Emergency Medicine

    Key finding: Twenty-six participants (15 ED clinicians, 3 caregivers, 8 community advisors) contributed perspectives. +4 more findings

  4. 2026-03-01
  5. 2026-03-01

    Impact of annual wellness visits on preventing falls and fractures for Alzheimer’s disease and related dementias older adults

    ✓ Peer-reviewed Clinical safety Age and Ageing

    Key finding: AWVs were associated with reduced risks for falls (HR: 0.976 for 2 AWVs; 0.936 for ≥3 AWVs) and fractures (HR: 0.978 for 1 AWV; 0.960 for 2 AWVs; 0.927 for ≥3 AWVs), with greater reductions observed with more AVWs. +4 more findings

  6. 2026-03-01

    Long‐term adherence and changes in the Mediterranean and MIND diets in relation to dementia risk and cognitive function

    ✓ Peer-reviewed Prevention trials Alzheimer s & Dementia

    Key finding: Participants in the highest versus lowest MedDiet and MIND categories had 21% (hazard ratio [HR] = 0.79, 95% confidence interval [CI]: 0.73-0.84) and 14% (HR = 0.86, 95% CI: 0.81-0.91) lower dementia risk, respectively. +3 more findings

  7. 2026-03-01

    The spleen–brain axis in Alzheimer's disease and related dementias: Integrating immune and metabolic regulation

    ✓ Peer-reviewed Disease mechanisms Alzheimer s & Dementia

    Key finding: Emerging evidence highlights the central role of peripheral immune-metabolic regulation in the pathogenesis of Alzheimer's disease and related dementias (ADRD). +4 more findings

  8. 2026-03-01

    Psychometric modeling of Boston process approach data for dementia prediction in the Framingham Heart Study

    ✓ Peer-reviewed Long-term cohort studies Journal of the International Neuropsychological Society

    Key finding: Participants were older adults (mean age 71.5 ± 8.7 years), primarily female (54.2%), and non-Hispanic White (96.5%). +4 more findings

  9. 2026-03-01

    Impact of anticoagulation on cognitive decline and clinical outcomes in patients with atrial fibrillation and dementia: A retrospective cohort study

    ✓ Peer-reviewed Cognitive tests and assessment Journal of Alzheimer s Disease Reports

    Key finding: In this retrospective, confounder-adjusted study, anticoagulation was associated with slower cognitive/functional decline and lower hospitalization/mortality risk in AF and dementia patients. +2 more findings

  10. 2026-03-01

    Developments on BACE 1 Inhibitors as Anti‐Alzheimer Agents: A Perspective on Medicinal Chemistry‐Based Advances

    ✓ Peer-reviewed Risk genes beyond APOE Archiv der Pharmazie

    Key finding: Numerous pathogenic hypotheses have been proposed to explain this mechanism; however, the amyloid cascade hypothesis remains the most widely accepted theory, as it suggests that β-site amyloid precursor protein-cleaving enzyme 1 (BACE1) plays a critical role in the generation of Aβ peptides.

  11. 2026-03-01

    Discriminative Plasma Lipidomic Signatures of Dementia with Lewy Bodies and Alzheimer’s Disease: A Targeted Mass Spectrometry and Machine Learning Approach

    ✓ Peer-reviewed Digital health tools Neuropsychiatric Disease and Treatment

    Key finding: Significant alterations were observed in 7 lipid classes and 65 specific lipid species in DLB compared to AD. +4 more findings

  12. 2026-03-01

    Effect of Mindfulness-Based Stress Reduction Activities on Family Caregiver Burden in Patients With Dementia—A Pilot Study

    ✓ Peer-reviewed Caregiving Home Healthcare Now

    Key finding: Following the intervention, caregivers demonstrated significant improvements, including reduced perceived burden, lower levels of depression, anxiety, and stress, and improved functional engagement. +1 more finding

  13. 2026-03-01

    Eye‐Tracking‐Based Cognitive Assessment Predicts the Risk of Memory Decline: A Community‐Based Cohort Study

    ✓ Peer-reviewed Getting a diagnosis Geriatrics and gerontology international/Geriatrics & gerontology international

    Key finding: Approximately half (54.5%, 35/55) of participants showed a decline in RBMT scores during the 2-year follow-up and were defined as the memory decline group. +3 more findings

  14. 2026-03-01

    Relationship between APOE Genotype Status and Imaging Features in Patients with Alzheimer Disease Being Considered for Antiamyloid β Therapy

    ✓ Peer-reviewed Genetics American Journal of Neuroradiology

    Key finding: A total of 85 patients were included in the study with rare genotypes excluded from analysis (3 patients). +4 more findings

  15. 2026-03-01

    ACONAMI : A Case for Asian Mental Health Transformation

    ✓ Peer-reviewed Health systems and care delivery Asia-Pacific Psychiatry

    Key finding: Its collective ethos and measurable outputs provide a working model for advancing an Asian approach to mental health transformation, one that is equitable, culturally grounded, and globally relevant. +4 more findings

  16. 2026-03-01

    Plasma Phosphorylated Tau 217 Cutoffs for Amyloid Pathology and Kidney Function, Body Mass Index, and Anemia

    ✓ Peer-reviewed Getting a diagnosis JAMA neurology

    Key finding: In the UGOT cohort, the optimal cutoff improved diagnostic accuracy compared with the standard single cutoff, particularly in CKD and anemia (CKD: from 0.65; 95% CI, 0.57-0.72; to 0.83; 95% CI, 0.76-0.89; anemia: from 0.80; 95% CI, 0.76-0.84; to 0.86; 95% CI, 0.82-0.90), with consistent findings in the Roche cohort. +3 more findings

February 2026 9

  1. 2026-02-27
  2. 2026-02-27

    Neighborhood food store and subsequent health and well-being of older adults in Japan: an outcome-wide study

    ✓ Peer-reviewed Risk factors Archives of gerontology and geriatrics

    Key finding: Compared to older adults who reported having many availability of neighborhood food stores, those reporting fewer stores were associated with less favorable outcomes in 5 of 7 domains; physical/cognitive health (low self-rated health and Instrumental activities of daily living), health behaviors (low frequency of going out), mental health (more depressive symptoms and hopeless), psychological well-being (low happiness and life satisfaction), cognitive social capital (low community attachment). +1 more finding

  3. 2026-02-27

    A qualitative inquiry about end-of-life care for people with advanced dementia: “Planning ahead not in reality”

    ✓ Peer-reviewed End-of-life care Geriatric Nursing

    Key finding: Six key themes were identified: Inadequate preparation, guidance and access to appropriate resources; Taboo and misunderstanding: talking about death; Dementia as a terminal illness and the role of palliative care; Key time points, critical events and decisions; Planning ahead not in reality; Family issues and dynamics. +4 more findings

  4. 2026-02-27

    Circulating immune cell phenotypes are associated with inflammatory biomarkers in dementia-free participants from the Framingham Heart Study Offspring cohort

    ✓ Peer-reviewed Long-term cohort studies Scientific Reports

    Key finding: Higher levels of CD8 Cytotoxic T cells, CD8 + CD27-, CD8 effector T cells, and interferon gamma-producing CD8 T cells (Tc1) were all associated with higher levels of soluble CD8 alpha chain (CD8A). +3 more findings

  5. 2026-02-27

    Vitamina E e outros antioxidantes na síndrome de Down para pacientes com demência: evidências iniciais com foco em marcadores genéticos

    ✓ Peer-reviewed Down syndrome and Alzheimer's Jornal de Assistência Farmacêutica e Farmacoeconomia

    Key finding: No entanto, os resultados dos estudos clínicos apresentam divergências entre si, além de limitações metodológicas, pequeno tamanho amostral e variabilidade na definição dos desfechos. +4 more findings

  6. 2026-02-27

    EEG microstate alterations in Parkinson’s disease dementia

    ✓ Peer-reviewed Getting a diagnosis Scientific Reports

    Key finding: Significant group differences were found in microstate dynamics. +3 more findings

  7. 2026-02-26

    Predicting rates of cognitive and functional decline in Alzheimer’s disease and mild cognitive impairment

    ✓ Peer-reviewed Mild cognitive impairment Communications Medicine

    Key finding: The MMSE model achieves a mean absolute error (MAE) of 1.84 (95% CI: 1.64-2.04) internally and 2.19 in external validation. +4 more findings

  8. 2026-02-26

    Multi-class Alzheimer’s disease (AD) classification using Swin Transformer wavelet and Gray Wolf Optimization (GWO)

    ✓ Peer-reviewed Brain scans and imaging Intelligence-Based Medicine

    Key finding: This is while the EfficientNet model is the lightest in these criteria. • A hybrid deep learning framework combining Swin Transformer, wavelet transform, and Gray Wolf Optimization is proposed for multi-class Alzheimers disease MRI classification. • Wavelet decomposition enhances multi-scale frequency feature extraction, improving discrimination between dementia stages compared with baseline CNN models.

  9. 2026-02-26

    Epilepsy and Alzheimer Disease: Epidemiologic, Clinical, Molecular, and Neuropathologic Convergences and Divergences

    ✓ Peer-reviewed Tau biomarkers Neurology. Clinical practice

    Key finding: Alzheimer disease (AD) and epilepsy are major causes of neurologic disability and are reciprocally related: epileptiform discharges, subclinical seizures, and epilepsy are more prevalent in patients with AD compared with controls; progressive cognitive impairment commonly afflicts epilepsy patients; and late-onset epilepsy patients have higher rates of new-onset dementia. +3 more findings

Browse the library by subject, with the full score breakdown →